Tìm theo
: 59323 mục trong 2967 trang
AZ
Xem
Nhóm
Thuốc Gốc
Ecabet
ecabet, ecabet sodium
For the treatment of reflux oesophagitis and peptic ulcer disease.
Thuốc Gốc
Ibudilast
2 isopropyl 3 isobutyrylpyrazolo 1 5 a pyridine, 3 isobutyryl 2 isopropylpyrazolo 1 5 a pyridine, 3 isobutyryl 2 isopropylpyrazolo 1 5 a pyridine
For the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
Thuốc Gốc
iCo-007
Various eye diseases
Thuốc Gốc
AST-120
Crohn's Disease, Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome (IBS),and Gastrointestinal Diseases
Thuốc Gốc
Rotigotine
For use/treatment in neurologic disorders and parkinson's disease as well as moderate-to-severe primary Restless Legs Syndrome.
Thuốc Gốc
Samarium (153sm) lexidronam
samarium sm 153 lexidronam
Investigated for use/treatment in bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.
Thuốc Gốc
transdermal testosterone gel
Investigated for use/treatment in male hormonal deficiencies/abnormalities and sexual dysfunction (female).
Thuốc Gốc
hepatitis B immune globulin
Investigated for use/treatment in hepatitis (viral, B), liver transplant surgery, and pediatric indications.
Thuốc Gốc
inhaled insulin
Type 2 Diabetes
Thuốc Gốc
SLV 308
Investigated for use/treatment in depression and parkinson's disease.
Thuốc Gốc
S-8184
Ovarian cancer or primary peritoneal carcinoma
Thuốc Gốc
MCC
Bladder cancer
Thuốc Gốc
HIIP
Investigated for use/treatment in diabetes mellitus type 1 and 2.
Thuốc Gốc
CA4P
Thuốc Gốc
SB-249553
lung cancer/melanoma
Thuốc Gốc
FTY 720
Investigated for use/treatment in immunosuppressive, multiple sclerosis, and transplant (rejection).
Thuốc Gốc
anecortave acetate
Investigated for use/treatment in glaucoma and macular degeneration.
Thuốc Gốc
MPC-7869
Investigated for use/treatment in alzheimer's disease and prostate cancer.
Thuốc Gốc
SPP 301
Investigated for use/treatment in cardiovascular disorders and neuropathy (diabetic).
Thuốc Gốc
lidocaine patch
Investigated for use/treatment in pain (acute or chronic).